Volumetric Analysis of Peri-Implant Soft Tissue Changes Between Polyethereketone(PEEK) Anatomic Healing Abutments and Standard Healing Abutments in Posterior Single Implant Restorations
anatomic
2 other identifiers
interventional
38
1 country
1
Brief Summary
This prospective randomized clinical trial will evaluate the clinical outcomes of the implant crown fabricated with standard scan body (control) and polyetheretherketone (PEEK) anatomic healing abutment (test).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2026
CompletedStudy Start
First participant enrolled
May 23, 2026
CompletedFirst Posted
Study publicly available on registry
June 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2028
June 3, 2026
May 1, 2026
2.1 years
May 22, 2026
May 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
volumetric soft tissue analysis
Three-dimensional volumetric analysis changes at healed sites before implant placement and after implant crown loading
12 months
Secondary Outcomes (1)
volumetric analysis changes
12 months
Other Outcomes (1)
Pink Esthetic White Esthetic Score
12 months
Study Arms (2)
Group A: Control
PLACEBO COMPARATORMonolithic zirconia screw retained crown conditioned with titanium standard healing abutment (SHA) and fabricated with standard monoscan body
Group B: PEEK AHA
ACTIVE COMPARATORMonolithic zirconia screw retained crown conditioned and fabricated with AHA digital workflow
Interventions
polyetheretherketone (PEEK) anatomic healing abutment versus standard anatomic healing abutment
Eligibility Criteria
You may qualify if:
- legally competent to provide written informed consent form prior to any study related procedures.
- Subjects of either sex or aged 18 above
- requires replacement of a single missing posterior tooth with adequate mesiodistal dimension (≥8 mm)
- intact adjacent teeth on both sides with existing opposing tooth condition
- good oral hygiene, plaque score \<25% bpe1
- adequate keratinized mucosa width (kmw) minimum 6 mm at the edentulous site
- adequate bone volume to accommodate the planned dental implant placement of 5.5 mm diameter and 10 mm in length as verifified by Cone Beam Computed Tomography (CBCT)
- adequate interoccusal distance (crown height space) of at least 6mm measured from alveolar crest to the occlusal table.
You may not qualify if:
- Localized or generalized periodontitis
- Presence of active acute infection
- History of malignancy, radiotherapy or chemotherapy
- Bone metabolic diseases (e.g.: osteogenesis imperfecta, Paget's disease) or current use of medications affecting bone metabolism
- Untreated bruxism or parafunctional habits Docusign Envelope ID: FFD7C6C1-66CB-4359-9662-63230F769528 22
- Severe occlusal discrepancy
- Any medical condition contraindicating implant placement or alter daily activities to a level consistent with ASA (American Society of Anesthesiologist) III classification (including cardiovascular, hepatic, renal, gastrointestinal, metabolic, neurologic, pulmonary, endocrine, autoimmune or psychiatric disorders)
- Subjects in need of bone grafting at the site of intended implantation site.
- Subjects that are pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universiti Teknologi MARA
Sungai Buloh, Selangor, 42300, Malaysia
Study Officials
- STUDY DIRECTOR
Professor Dr Mohd Yusmiaidil Putera Mohd Yusoff, phd
Universiti Teknologi Mara
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- yes, co investogator
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assoc Prof
Study Record Dates
First Submitted
May 22, 2026
First Posted
June 3, 2026
Study Start
May 23, 2026
Primary Completion (Estimated)
July 1, 2028
Study Completion (Estimated)
October 1, 2028
Last Updated
June 3, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
In in the agreement with Institute of Straumann AG